Pfizer States That Its Vaccine Is Very Effective In Children Aged 5 to 11

Pfizer States That Its Vaccine Is Very Effective In Children Aged 5 to 11

Pfizer released data on Friday showing that its vaccine had a 90.7% effectiveness rate in preventing symptomatic Covid19 in a clinical study involving children aged 5 to 11. 

The company submitted the information to the Food and Drug Administration, which was due to release its analysis of the data later today. 

The children in the study received a dose of 10 micrograms, which was lower than the dose of 30 micrograms given to adults. 

The company said the dosage was safe and the study participants saw only mild side effects. 

The company released the data ahead of a meeting next week where F's expert advisers will decide whether to recommend the agency to authorize the vaccine for children in this age group. 

 have alFederal regulators ready made the vaccine available for ages 12 and older. If F.clears the vaccine for children ages 5 to 11 - a move that could help protect more than 28 million people in the United States - the Centers for Disease Control and Prevention next month will then make recommendations to the agency on how the injections should be administered. 

According to federal data, 66 percent of the population of the United States. have received at least one dose of the Covid vaccine, while 57% are fully vaccinated.

Popular Posts

Omega-3 Fish Oil Supplements May Help You Feel Less Angry and Irritable

Epilepsy In Children: Understanding And Managing Seizure Disorder

Foods That Are Good For Your Heart

Statins May Help Prevent Cancer In Addition To Lowering Cholesterol

A small plane made a daring emergency landing in a residential area on the outskirts of Paris

Met Office Warns Of Severe Weather Conditions With Strong Winds And Heavy Rain Sweeping Across The UK

Top 20 High-Protein Foods to Fuel Your Workout

Ear Infections In Babies And Children

What Is Gut Health?

Understanding Dizziness: Symptoms, Causes, And Treatment Options